Ind Swift Share Price
Sector: Major Drugs
15.12 +0.40 (2.72%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
14.99
Today’s High
15.22
52 Week Low
12.00
52 Week High
34.49
15.12 +0.39 (2.65%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
14.80
Today’s High
15.28
52 Week Low
12.00
52 Week High
34.70
Key Metrics
- Market Cap (In Cr) 82.57
- Beta 0.51
- Div. Yield (%) 0
- P/B -
- TTM P/E 2.78
- Peg Ratio 0.11
- Sector P/E 24.5
- Open Price 15
- Prev Close 14.72
Ind Swift Analysis
Price Analysis
-
1 Week17.75%
-
3 Months1.17%
-
6 Month-29.11%
-
YTD-55.43%
-
1 Year-30.52%
Risk Meter
- 66% Low risk
- 66% Moderate risk
- 66% Balanced Risk
- 66% High risk
- 66% Extreme risk
Ind Swift News
Army engages suspected drones near IB in Jammu's Sam, confirms ‘no enemy threat’
2 min read . 13 May 2025Pakistan violates ceasefire across LoC again, Indian Army responds
2 min read . 28 Apr 2025India eyes swift trade pact with US amid higher tariff pressures on Asian rivals
9 min read . 04 Apr 2025Risky or rewarding? Using personal loans to fuel stock market dreams
3 min read . 11 Mar 2025Ind Swift Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 502.25
- Selling/ General/ Admin Expenses Total
- 78.32
- Depreciation/ Amortization
- 27.11
- Other Operating Expenses Total
- 88.79
- Total Operating Expense
- 475.39
- Operating Income
- 26.86
- Net Income Before Taxes
- 16.46
- Net Income
- 14.23
- Diluted Normalized EPS
- 3.44
- Period
- 2024
- Total Assets
- 654.47
- Total Liabilities
- 1345.3
- Total Equity
- -690.83
- Tangible Book Valueper Share Common Eq
- -129.48
- Period
- 2024
- Cashfrom Operating Activities
- 15.28
- Cashfrom Investing Activities
- 76.61
- Cashfrom Financing Activities
- -42.08
- Net Changein Cash
- 49.81
- Period
- 2023
- Total Revenue
- 410.96
- Selling/ General/ Admin Expenses Total
- 69.15
- Depreciation/ Amortization
- 28.67
- Other Operating Expenses Total
- 81.71
- Total Operating Expense
- 336.99
- Operating Income
- 73.97
- Net Income Before Taxes
- 26.04
- Net Income
- 26.04
- Diluted Normalized EPS
- -6.42
- Period
- 2023
- Total Assets
- 649.21
- Total Liabilities
- 1353.91
- Total Equity
- -704.7
- Tangible Book Valueper Share Common Eq
- -132.3
- Period
- 2023
- Cashfrom Operating Activities
- 73.05
- Cashfrom Investing Activities
- -29.35
- Cashfrom Financing Activities
- -46.56
- Net Changein Cash
- -2.85
- Period
- 2022
- Total Revenue
- 397.71
- Selling/ General/ Admin Expenses Total
- 63.15
- Depreciation/ Amortization
- 32.07
- Other Operating Expenses Total
- 78.18
- Total Operating Expense
- 383.7
- Operating Income
- 14.02
- Net Income Before Taxes
- -19.6
- Net Income
- -20.02
- Diluted Normalized EPS
- -3.79
- Period
- 2022
- Total Assets
- 631.76
- Total Liabilities
- 1352.08
- Total Equity
- -720.32
- Tangible Book Valueper Share Common Eq
- -134.91
- Period
- 2022
- Cashfrom Operating Activities
- 50.2
- Cashfrom Investing Activities
- -18.42
- Cashfrom Financing Activities
- -44.6
- Net Changein Cash
- -12.81
- Period
- 2021
- Total Revenue
- 356.06
- Selling/ General/ Admin Expenses Total
- 55.79
- Depreciation/ Amortization
- 32.7
- Other Operating Expenses Total
- 72.35
- Total Operating Expense
- 348.58
- Operating Income
- 7.48
- Net Income Before Taxes
- -29.49
- Net Income
- -29.82
- Diluted Normalized EPS
- -5.36
- Period
- 2021
- Total Assets
- 671.57
- Total Liabilities
- 1366.74
- Total Equity
- -695.16
- Tangible Book Valueper Share Common Eq
- -130.55
- Period
- 2021
- Cashfrom Operating Activities
- 83.19
- Cashfrom Investing Activities
- -16.71
- Cashfrom Financing Activities
- -54.25
- Net Changein Cash
- 12.23
- Period
- 2020
- Total Revenue
- 329.52
- Selling/ General/ Admin Expenses Total
- 52.53
- Depreciation/ Amortization
- 33.59
- Other Operating Expenses Total
- 66.68
- Total Operating Expense
- 333.29
- Operating Income
- -3.77
- Net Income Before Taxes
- -16.66
- Net Income
- -19.12
- Diluted Normalized EPS
- -4.3
- Period
- 2020
- Total Assets
- 601.65
- Total Liabilities
- 1314.76
- Total Equity
- -713.12
- Tangible Book Valueper Share Common Eq
- -134.62
- Period
- 2020
- Cashfrom Operating Activities
- 34.6
- Cashfrom Investing Activities
- -11.35
- Cashfrom Financing Activities
- -26.2
- Net Changein Cash
- -2.96
- Period
- 2019
- Total Revenue
- 289.03
- Selling/ General/ Admin Expenses Total
- 49.93
- Depreciation/ Amortization
- 33.97
- Other Operating Expenses Total
- 67.26
- Total Operating Expense
- 285.49
- Operating Income
- 3.54
- Net Income Before Taxes
- 8.19
- Net Income
- 8.19
- Diluted Normalized EPS
- -3.21
- Period
- 2019
- Total Assets
- 598.42
- Total Liabilities
- 1275.16
- Total Equity
- -676.74
- Tangible Book Valueper Share Common Eq
- -128.65
- Period
- 2019
- Cashfrom Operating Activities
- 42.79
- Cashfrom Investing Activities
- -13.71
- Cashfrom Financing Activities
- -13.03
- Net Changein Cash
- 16.05
- Period
- 2024-12-31
- Total Revenue
- 120.13
- Selling/ General/ Admin Expenses Total
- 21.15
- Depreciation/ Amortization
- 5.57
- Other Operating Expenses Total
- 36.2
- Total Operating Expense
- 118.37
- Operating Income
- 1.77
- Net Income Before Taxes
- -5.5
- Net Income
- -5.5
- Diluted Normalized EPS
- -1.02
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 136.35
- Selling/ General/ Admin Expenses Total
- 21.12
- Depreciation/ Amortization
- 5.39
- Other Operating Expenses Total
- 30.94
- Total Operating Expense
- 127.33
- Operating Income
- 9.01
- Net Income Before Taxes
- 4.11
- Net Income
- 4.11
- Diluted Normalized EPS
- 0.76
- Period
- 2024-09-30
- Total Assets
- 685.57
- Total Liabilities
- 1344.04
- Total Equity
- -658.47
- Tangible Book Valueper Share Common Eq
- -123.49
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -16.24
- Cashfrom Investing Activities
- 31.76
- Cashfrom Financing Activities
- -9.81
- Net Changein Cash
- 5.71
- Period
- 2024-06-30
- Total Revenue
- 113.85
- Selling/ General/ Admin Expenses Total
- 19.93
- Depreciation/ Amortization
- 5.37
- Other Operating Expenses Total
- 26.99
- Total Operating Expense
- 116
- Operating Income
- -2.15
- Net Income Before Taxes
- 28.24
- Net Income
- 28.24
- Diluted Normalized EPS
- 5.21
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 135.23
- Selling/ General/ Admin Expenses Total
- 20.9
- Depreciation/ Amortization
- 6.88
- Other Operating Expenses Total
- 28.3
- Total Operating Expense
- 127.62
- Operating Income
- 7.61
- Net Income Before Taxes
- 39.77
- Net Income
- 37.54
- Diluted Normalized EPS
- 6.95
- Period
- 2024-03-31
- Total Assets
- 654.47
- Total Liabilities
- 1345.3
- Total Equity
- -690.83
- Tangible Book Valueper Share Common Eq
- -129.48
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 15.28
- Cashfrom Investing Activities
- 76.61
- Cashfrom Financing Activities
- -42.08
- Net Changein Cash
- 49.81
- Period
- 2023-12-31
- Total Revenue
- 102.56
- Selling/ General/ Admin Expenses Total
- 20.46
- Depreciation/ Amortization
- 6.78
- Other Operating Expenses Total
- 21.32
- Total Operating Expense
- 104.85
- Operating Income
- -2.29
- Net Income Before Taxes
- -14.97
- Net Income
- -14.97
- Diluted Normalized EPS
- -2.76
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Ind Swift Technical
Moving Average
SMA
- 5 Day13.8
- 10 Day13.25
- 20 Day13.25
- 50 Day13.62
- 100 Day18
- 300 Day20.54
Ind Swift Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Bharat Immunologica And Bio Corp
- 24.36
- 0.98
- 4.19
- 35.88
- 19
- 105.91
- Makers Laboratories
- 165.35
- 27.3
- 19.78
- 230
- 114
- 97.59
- Ind Swift
- 15.12
- 0.4
- 2.72
- 34.49
- 12
- 82.57
- Zenlabs Ethica
- 32.84
- 0.04
- 0.12
- 52.1
- 27.33
- 21.38
- Patron Exim
- 6.79
- 0
- 0
- 9.8
- 4.8
- 15.74
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Bharat Immunologica And Bio Corp
- -
- 1.15
- -23.67
- -16.7
- Makers Laboratories
- -
- 1.29
- -2.32
- 1.31
- Ind Swift
- 4.29
- -
- -
- -1.44
- Zenlabs Ethica
- 80
- 2.05
- 6.1
- 0.94
- Patron Exim
- 22.03
- 0.4
- -
- -
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 11-Feb-25
- Quarterly Results
- 14-Nov-24
- Quarterly Results
- 13-Aug-24
- Quarterly Results
- 14-May-24
- Audited Results
- 14-Feb-24
- Quarterly Results
- 13-Feb-24
- Quarterly Results
- 09-Nov-23
- Quarterly Results
- 10-Aug-23
- Quarterly Results
- 30-May-23
- Audited Results
- 13-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 22-Feb-25
- 20-Jan-25
- COM
- 30-Sept-24
- 19-Aug-24
- AGM
- 19-Mar-24
- 15-Feb-24
- POM
- 06-Oct-23
- 03-Oct-23
- EGM
- 30-Sept-23
- 31-Aug-23
- AGM



